Graphene Oxide: Purified Graphene Oxide Dispersions Lack In Vitro Cytotoxicity and In Vivo Pathogenicity (Adv. Healthcare Mater. 3/2013). Issue 3 (6th March 2013)

• Record Type: Journal Article
• Authors: Ali‐Boucetta, Hanene; Bitounis, Dimitrios; Raveendran‐Nair, Rahul; Servant, Ania; Van den Bossche, Jeroen; Kostarelos, Kostas
• Is Part Of: Advanced healthcare materials. Volume 2:Issue 3(2013:Mar.)
• Page Start: 512
• Page End: 512
• Publication Date: 2013-03-06
• Subjects: Biomedical materials -- Periodicals; 610.28
• DOI: 10.1002/adhm.201370014
• Languages: English
• ISSNs: 2192-2640

Abstract

<abstract abstract-type="graphical" xml:lang="en"> <title> <x xml:space="preserve">Abstract</x> </title> <p>Preparation of a high dispersibility graphene oxide (GO) that can be reliably used in biological investigations is reported by Kostas Kostarelos and co‐workers <ext-link ext-link-type="doi" xlink:type="simple" xmlns:xlink="http://www.w3.org/1999/xlink">on page 433</ext-link>. Exposure of cells and tissue to the graphene oxide indicated a lack of cytotoxic responses in human cell cultures (in vitro) and after injection to living animals (in vivo). <boxed-text content-type="graphic" position="anchor" orientation="portrait"><graphic position="anchor" mimetype="image" xlink:href="ark:/27927/pgg1v7ccrj5" orientation="portrait" xlink:type="simple" xmlns:xlink="http://www.w3.org/1999/xlink" /></boxed-text></p> </abstract>